Adrenergic, histamine H1, and muscarinic receptors

The Adrenergic, histamine H1, and muscarinic receptors represent a collective group of G protein-coupled receptors (GPCRs) that are often co-targeted by multi-receptor ligands, particularly in the treatment of psychiatric disorders (StatPearls, 2023). Adrenergic receptors (alpha and beta) are essential for sympathetic nervous system signaling, regulating heart rate and blood pressure (NCBI, 2022). Histamine H1 receptors play a pivotal role in the allergic response and the maintenance of wakefulness in the brain (UniProt, 2024). Muscarinic receptors (M1-M5) mediate parasympathetic effects, including smooth muscle contraction and cognitive processes (PubMed, 2021). Drugs such as atypical antipsychotics (e.g., Clozapine) and tricyclic antidepressants (e.g., Amitriptyline) frequently act as antagonists across these three systems. This polypharmacology can lead to a combination of therapeutic benefits and significant side effects like sedation, orthostatic hypotension, and anticholinergic effects (PubChem, 2024). Understanding the interplay between these receptors is crucial for managing the side-effect profiles of many CNS-active medications.

Other names

Biogenic amine receptorsGPCR multi-target profileAmine-type G protein-coupled receptors

Competitive antagonism of alpha-adrenergic, histamine H1, and muscarinic acetylcholine receptors, inhibiting the binding of endogenous catecholamines, histamine, and acetylcholine (StatPearls, 2023).